Skip to main content

Table 2 Anti-HBs levels in vaccinated newborns with different anti-preS1 peptide (21–32, 32–47, 94–117) reactivities at time T9

From: PreS1 epitope recognition in newborns after vaccination with the third-generation Sci-B-Vac™ vaccine and their relation to the antibody response to hepatitis B surface antigen

Reactivity with Number Anti-HBs (IU/L) Probability*
3 preS1 peptides n = 7 23 688 ± 6 183 a/  
2 preS1 peptides n = 4 22 890 ± 10 670 b/ ns
1 preS1 peptide n = 12 11 919 ± 8 669 c/ p < 0.025
0 preS1 peptide n = 5 2 065 ± 1 105 d/ p < 0.05
  1. *the a/ compared with the b/, c/ or d/ groups of vaccinated newborns (Mann-Whitney test)
  2. ns = not significant
  3. T9 = three months after the third injection
  4. Anti-HBs (mean ± SEM)